MIF as a biomarker and therapeutic target for overcoming resistance to proteasome inhibitors in human myeloma
MIF 作为克服人类骨髓瘤蛋白酶体抑制剂耐药性的生物标志物和治疗靶点
期刊:Blood
影响因子:21
doi:10.1182/blood.2020005795
Qiang Wang, Dongyu Zhao, Miao Xian, Zhuo Wang, Enguang Bi, Pan Su, Jianfei Qian, Xingzhe Ma, Maojie Yang, Lintao Liu, Youli Zu, Sai Ravi Pingali, Kaifu Chen, Zhen Cai, Qing Yi